2019 Q1 Form 10-K Financial Statement

#000161883519000031 Filed on March 01, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2018
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.743M $5.210M $34.23M
YoY Change -36.4% 157.92% 461.15%
% of Gross Profit
Research & Development $7.889M $9.770M $43.42M
YoY Change -34.03% 2691.43% 84.44%
% of Gross Profit
Depreciation & Amortization $70.00K $60.00K $260.0K
YoY Change 0.0% 200.0% 420.0%
% of Gross Profit
Operating Expenses $13.63M $14.98M $77.64M
YoY Change -35.04% -2.38% 117.56%
Operating Profit -$13.63M -$77.64M
YoY Change -35.04% 117.56%
Interest Expense -$4.420M $30.00K $130.0K
YoY Change -14833.33% 200.0% 160.0%
% of Operating Profit
Other Income/Expense, Net -$4.436M $0.00 -$48.07M
YoY Change -90.77% -100.0% -30.95%
Pretax Income -$18.07M -$14.98M -$125.7M
YoY Change -73.84% 534.75% 19.38%
Income Tax $0.00 $0.00 $2.000K
% Of Pretax Income
Net Earnings -$18.07M -$14.98M -$125.7M
YoY Change -73.84% -23.15% 19.38%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$672.2K -$579.3K -$5.740M
COMMON SHARES
Basic Shares Outstanding 28.16M shares 25.87M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q1 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $200.0K $1.300M $1.300M
YoY Change -96.0% -61.76% -61.76%
Cash & Equivalents $184.0K $1.330M $1.300M
Short-Term Investments
Other Short-Term Assets $1.000M $700.0K $700.0K
YoY Change -54.55% 16.67% 16.67%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.413M $2.478M $2.500M
YoY Change -80.39% 5.27% -37.5%
LONG-TERM ASSETS
Property, Plant & Equipment $527.0K $593.0K $600.0K
YoY Change -32.69% -30.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $649.0K $939.0K $400.0K
YoY Change -35.29% 25.2% 300.0%
Total Long-Term Assets $1.821M $1.532M $1.500M
YoY Change 1.96% -4.13% 1400.0%
TOTAL ASSETS
Total Short-Term Assets $1.413M $2.478M $2.500M
Total Long-Term Assets $1.821M $1.532M $1.500M
Total Assets $3.234M $4.010M $4.000M
YoY Change -64.03% 1.47% -2.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.93M $8.882M $8.900M
YoY Change -10.34% -1.3% 1383.33%
Accrued Expenses $11.65M $11.51M $14.40M
YoY Change -7.48% -4.74% 1700.0%
Deferred Revenue
YoY Change
Short-Term Debt $4.000M $4.000M $4.000M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.09M $27.33M $27.30M
YoY Change 18.68% -73.56% 1850.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.09M $27.33M $27.30M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $32.09M $27.37M $27.40M
YoY Change 17.6% -73.59% 1857.14%
SHAREHOLDERS EQUITY
Retained Earnings -$451.2M -$433.1M
YoY Change 19.84% 40.96%
Common Stock $422.4M $409.8M
YoY Change 17.91% 2211.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$28.85M -$23.36M -$23.40M
YoY Change
Total Liabilities & Shareholders Equity $3.234M $4.010M $4.000M
YoY Change -64.03% 1.47% -2.44%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2018
OPERATING ACTIVITIES
Net Income -$18.07M -$14.98M -$125.7M
YoY Change -73.84% -23.15% 19.38%
Depreciation, Depletion And Amortization $70.00K $60.00K $260.0K
YoY Change 0.0% 200.0% 420.0%
Cash From Operating Activities -$7.678M -$10.25M -$56.50M
YoY Change -57.67% 334.32% 589.02%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $7.000K
YoY Change 16.67%
Acquisitions
YoY Change
Other Investing Activities $250.0K $0.00 $2.150M
YoY Change -88.37% 21400.0%
Cash From Investing Activities $250.0K -$10.00K $2.143M
YoY Change -88.37% 21330.0%
FINANCING ACTIVITIES
Cash Dividend Paid $200.0K $200.0K
YoY Change 0.0%
Common Stock Issuance & Retirement, Net $20.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $6.267M -500.0K $54.42M
YoY Change -68.48% -1766.67% 181290.0%
NET CHANGE
Cash From Operating Activities -$7.678M -10.25M -$56.50M
Cash From Investing Activities $250.0K -10.00K $2.143M
Cash From Financing Activities $6.267M -500.0K $54.42M
Net Change In Cash -$1.161M -10.76M $60.00K
YoY Change -129.79% 361.8% -100.74%
FREE CASH FLOW
Cash From Operating Activities -$7.678M -$10.25M -$56.50M
Capital Expenditures -$10.00K $7.000K
Free Cash Flow -$10.24M -$56.51M
YoY Change 333.9% 588.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q4 evfm Unrecognized Stock Based Compensation Expense
UnrecognizedStockBasedCompensationExpense
5100000 USD
CY2018 dei Amendment Flag
AmendmentFlag
false
CY2018 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018 dei Entity Registrant Name
EntityRegistrantName
EVOFEM BIOSCIENCES, INC.
CY2018 dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
CY2018 dei Document Type
DocumentType
10-K
CY2018 dei Entity Central Index Key
EntityCentralIndexKey
0001618835
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28156567 shares
CY2017Q1 evfm Early Lease Termination Fees
EarlyLeaseTerminationFees
55000 USD
CY2017 evfm Effective Income Tax Rate Reconciliation Accrual Of Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationAccrualOfUncertainTaxPositions
-0.0034
CY2018 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2018 evfm Effective Income Tax Rate Reconciliation Accrual Of Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationAccrualOfUncertainTaxPositions
-0.0057
CY2018 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2018Q2 dei Entity Public Float
EntityPublicFloat
16035680 USD
CY2017 evfm Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsPercent
-0.1975
CY2018 evfm Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants Percent
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantsPercent
-0.0002
CY2016Q3 evfm Disposal Group Including Discontinued Operation Consideration Receivable Stated Rate
DisposalGroupIncludingDiscontinuedOperationConsiderationReceivableStatedRate
0.05
CY2018 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2018 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017Q4 evfm Accrued Clinical Studies Current
AccruedClinicalStudiesCurrent
8789000 USD
CY2018Q4 evfm Accrued Clinical Studies Current
AccruedClinicalStudiesCurrent
9153000 USD
CY2017Q4 evfm Accrued Deferred Offering Costs Current
AccruedDeferredOfferingCostsCurrent
135000 USD
CY2018Q4 evfm Accrued Deferred Offering Costs Current
AccruedDeferredOfferingCostsCurrent
127000 USD
CY2017Q4 evfm Accrued Directors Fees And Related Expenses Current
AccruedDirectorsFeesAndRelatedExpensesCurrent
247000 USD
CY2018Q4 evfm Accrued Directors Fees And Related Expenses Current
AccruedDirectorsFeesAndRelatedExpensesCurrent
67000 USD
CY2017Q4 evfm Accrued Franchise Tax
AccruedFranchiseTax
12000 USD
CY2018Q4 evfm Accrued Franchise Tax
AccruedFranchiseTax
188000 USD
CY2017Q4 evfm Accrued Interest Unpaid Sublicense Fees
AccruedInterestUnpaidSublicenseFees
76000 USD
CY2018Q4 evfm Accrued Interest Unpaid Sublicense Fees
AccruedInterestUnpaidSublicenseFees
174000 USD
CY2017Q4 evfm Accrued Sublicense Fees
AccruedSublicenseFees
2000000 USD
CY2018Q4 evfm Accrued Sublicense Fees
AccruedSublicenseFees
1117000 USD
CY2018Q2 evfm Class Of Warrant Or Right Issued In Transaction
ClassOfWarrantOrRightIssuedInTransaction
8500000 shares
CY2018Q4 evfm Common Stock Reserved Upon Exercise Of Common Stock Warrants
CommonStockReservedUponExerciseOfCommonStockWarrants
4775886 shares
CY2018 evfm Deemed Contribution Upon Exchange Of Preferred Stock
DeemedContributionUponExchangeOfPreferredStock
49334000 USD
CY2017 evfm Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
137000 USD
CY2018 evfm Deferred Offering Costs Included In Accounts Payable And Accrued Expense
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense
94000 USD
CY2017 evfm Deferred Rent Adjustment
DeferredRentAdjustment
30000 USD
CY2018 evfm Deferred Rent Adjustment
DeferredRentAdjustment
242000 USD
CY2016Q3 evfm Disposal Group Including Discontinued Operation Consideration Receivable Annual Principal Payment
DisposalGroupIncludingDiscontinuedOperationConsiderationReceivableAnnualPrincipalPayment
300000 USD
CY2017 evfm Effective Income Tax Rate Reconciliation Deduction Loss On Issuance Of Warrants Percent
EffectiveIncomeTaxRateReconciliationDeductionLossOnIssuanceOfWarrantsPercent
0.0000
CY2018 evfm Effective Income Tax Rate Reconciliation Deduction Loss On Issuance Of Warrants Percent
EffectiveIncomeTaxRateReconciliationDeductionLossOnIssuanceOfWarrantsPercent
0.0801
CY2017 evfm Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
0.0019
CY2018 evfm Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
0.0003
CY2017 evfm Gain Loss On Issuance Of Convertible Preferred Stock
GainLossOnIssuanceOfConvertiblePreferredStock
-8522000 USD
CY2018 evfm Gain Loss On Issuance Of Convertible Preferred Stock
GainLossOnIssuanceOfConvertiblePreferredStock
0 USD
CY2015Q1 evfm Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2017 evfm Loss On Issuance Of Redeemable Convertible Preferred Stock And Related Warrants Net
LossOnIssuanceOfRedeemableConvertiblePreferredStockAndRelatedWarrantsNet
8522000 USD
CY2018 evfm Loss On Issuance Of Redeemable Convertible Preferred Stock And Related Warrants Net
LossOnIssuanceOfRedeemableConvertiblePreferredStockAndRelatedWarrantsNet
0 USD
CY2017 evfm Loss On Issuance Of Warrants
LossOnIssuanceOfWarrants
0 USD
CY2018 evfm Loss On Issuance Of Warrants
LossOnIssuanceOfWarrants
47920000 USD
CY2018Q4 evfm Notes Issued Stated Rate Monthly Percent Of Principal Permitted
NotesIssuedStatedRateMonthlyPercentOfPrincipalPermitted
0.01
CY2015Q1 evfm Operating Leases Number Of Renewal Options For Extended Terms
OperatingLeasesNumberOfRenewalOptionsForExtendedTerms
2 renewal_term
CY2017 evfm Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
0 USD
CY2018 evfm Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
37542000 USD
CY2014Q4 evfm Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfAdditionalSharesAuthorized
0.010
CY2017 evfm Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
18400000 USD
CY2018 evfm Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
200000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8999000 USD
CY2018 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
1900000 USD
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
8882000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12086000 USD
CY2018 evfm Warrants And Stock Issued During Period Value New Issues
WarrantsAndStockIssuedDuringPeriodValueNewIssues
14062000 USD
CY2018 evfm Weighted Average Remaining Period
WeightedAverageRemainingPeriod
P2Y2M26D
CY2018Q4 evfm Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
-24900000 USD
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
11513000 USD
CY2017Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
727000 USD
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
549000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
342000 USD
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
604000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
17731000 USD
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
409787000 USD
CY2018 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-1592000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
80000000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
861000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17842000 USD
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
861000 USD
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17842000 USD
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8191028 shares
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10543513 shares
CY2017Q4 us-gaap Assets
Assets
3952000 USD
CY2018Q4 us-gaap Assets
Assets
4010000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
2354000 USD
CY2018Q4 us-gaap Assets Current
AssetsCurrent
2478000 USD
CY2018Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
904000 USD
CY2017 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1211000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1300000 USD
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1330000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1701000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1761000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11487000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1701000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1761000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9786000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
60000 USD
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.23
CY2018Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2000000 shares
CY2018Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
11875 shares
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4775886 shares
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
10892432 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4051137 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2082053 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25867248 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2082053 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25867248 shares
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
0 USD
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
3000 USD
CY2017Q4 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
80 shares
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2018 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3000 USD
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2000 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2017Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
114000 USD
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
37000 USD
CY2017Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
42281000 USD
CY2018Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
53933000 USD
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
89000 USD
CY2018Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
672000 USD
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
48418000 USD
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
65205000 USD
CY2017Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3808000 USD
CY2018Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
5948000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2018Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
846000 USD
CY2018Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
747000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1394000 USD
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
3905000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
48418000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
65205000 USD
CY2017 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000 USD
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000 USD
CY2018 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.030
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
244000 USD
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
262000 USD
CY2017 us-gaap Depreciation Nonproduction
DepreciationNonproduction
200000 USD
CY2018 us-gaap Depreciation Nonproduction
DepreciationNonproduction
300000 USD
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
79870000 USD
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2016Q3 us-gaap Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net
DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
1300000 USD
CY2016Q3 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
1900000 USD
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5200000 USD
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.14
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.78
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-38.31
CY2017Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-10.55
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-55.78
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.62
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.11
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
CY2018Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.74
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.1057
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1283
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0003
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0001
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0046
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0056
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0293
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0103
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.2226
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.0019
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0034
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0021
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0135
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0160
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2392000 USD
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2924000 USD
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12148000 USD
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34227000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-105222000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-125670000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-105302000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-125710000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-80000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-40000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-105302000 USD
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-125710000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7052000 USD
CY2018 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-130000 USD
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
78870000 USD
CY2017Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0 claim
CY2018Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0 claim
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
3000 USD
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3799000 USD
CY2017 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
7319000 USD
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-795000 USD
CY2017 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
775000 USD
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
307000 USD
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-145000 USD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
11000 USD
CY2017 us-gaap Interest Paid Net
InterestPaidNet
15000 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
128000 USD
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
127000 USD
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
500000 USD
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
103627000 USD
CY2018Q4 us-gaap Liabilities
Liabilities
27366000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3952000 USD
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4010000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
103347000 USD
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27329000 USD
CY2017 us-gaap Liabilities Fair Value Adjustment
LiabilitiesFairValueAdjustment
-61175000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9212000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
54417000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
244000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
2143000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-19242000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-56500000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-5269000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-6512000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-74031000 USD
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-19493000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-105305000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-69056000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-23244000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-18431000 USD
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
-14981000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-125712000 USD
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6157000 USD
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-69615000 USD
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
48070000 USD
CY2017Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4147000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7409000 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-75085000 USD
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20671000 USD
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-109322000 USD
CY2018Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-69122000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-23244000 USD
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18431000 USD
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14981000 USD
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-125778000 USD
CY2017 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
0 USD
CY2018 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
46000 USD
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
353000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
154000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
64961000 USD
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000 USD
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 USD
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-48068000 USD
CY2018Q4 us-gaap Notes Issued1
NotesIssued1
4000000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
100000 USD
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
138000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
750000 USD
CY2017 us-gaap Notes Issued1
NotesIssued1
0 USD
CY2018 us-gaap Notes Issued1
NotesIssued1
4010000 USD
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
4010000 USD
CY2018 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
4913000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
6358000 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
9070000 USD
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
15346000 USD
CY2017 us-gaap Operating Expenses
OperatingExpenses
35687000 USD
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
20986000 USD
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
23242000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
18433000 USD
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
14981000 USD
CY2018 us-gaap Operating Expenses
OperatingExpenses
77642000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-35687000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-77642000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
978000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
777000 USD
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
201000 USD
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
939000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
166000 USD
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
0 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46000 USD
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-145000 USD
CY2017 us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
10665000 USD
CY2018 us-gaap Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
0 USD
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
200000 USD
CY2017 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
0 USD
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1418000 USD
CY2018 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
157000 USD
CY2018Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
1500000 USD
CY2017 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
713000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1190000 USD
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1197000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
848000 USD
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
593000 USD
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
431000 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
42000 USD
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1592000 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
653000 USD
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
717000 USD
CY2017 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
250000 USD
CY2018 us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
250000 USD
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20000000 USD
CY2017 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
9925000 USD
CY2018 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
0 USD
CY2016Q3 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
600000 USD
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23539000 USD
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43415000 USD
CY2017Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
490000 USD
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
431000 USD
CY2017Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
490000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-307277000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-433100000 USD
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-433146000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
861000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
17842000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.909
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.870
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.029
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
0.15
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
28333 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
12000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
32.34
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.99
CY2017Q4 us-gaap Share Price
SharePrice
0.31
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M25D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
35520
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.58
CY2017 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0 shares
CY2018 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0 shares
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
121315000 USD
CY2018 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
5226000 USD
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
42000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-181085000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-289546000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-23356000 USD
CY2018 us-gaap Stockholders Equity Change In Reporting Entity
StockholdersEquityChangeInReportingEntity
1946000 USD
CY2018Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
166.7000
CY2017 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
4017000 USD
CY2018 us-gaap Temporary Equity Accretion Of Dividends
TemporaryEquityAccretionOfDividends
223000 USD
CY2017 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
4017000 USD
CY2018 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
66000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
970000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1335000 USD
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2061000 USD
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
5000 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
370000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
564000 USD
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
162000 USD
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2018 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
0 USD
CY2018Q1 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
14100000 USD
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1959904 shares
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
21900574 shares
CY2018 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations of Credit Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents and restricted cash. Deposits in the Company&#8217;s checking and time deposit accounts are maintained in federally insured financial institutions in excess of federally insured limits. The Company invests in funds through a major U.S. bank and is exposed to credit risk in the event of default to the extent of amounts recorded on the consolidated balance sheets.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company has not experienced any losses in such accounts and believes it is not exposed to significant concentrations of credit risk on its cash, cash equivalents and restricted cash balances due to the financial position of the depository institutions in which these deposits are held.</font></div></div>
CY2018 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and the notes thereto. </font><font style="font-family:inherit;font-size:9pt;">S</font><font style="font-family:inherit;font-size:10pt;">ignificant estimates affecting amounts reported or disclosed in the consolidated financial statements include, but not limited to, the measurement of the Series D 2X liquidation preference, assumptions used in estimating the fair value of warrants issued in connection with the Merger, the useful lives of property and equipment, the recoverability of long-lived assets, preclinical and clinical trial accruals, assumptions used in estimating the fair value of stock-based compensation expense and other contingencies. The Company&#8217;s assumptions regarding the measurement of the Series D 2X liquidation preference and stock-based compensation are more fully described in </font><a style="font-family:inherit;font-size:10pt;" href="#s9C2FC6E1ACE55EA3BBF27A8B12AEF064"><font style="font-family:inherit;font-size:10pt;">Note 5 &#8212; Fair Value of Financial Instruments</font></a><font style="font-family:inherit;font-size:10pt;"> and </font><a style="font-family:inherit;font-size:10pt;" href="#s319B0DA926A350D2A840F986C95DB4BA"><font style="font-family:inherit;font-size:10pt;">Note 11 &#8212; Stock-based Compensation, </font></a><font style="font-family:inherit;font-size:10pt;">respectively. The Company bases its estimates on historical experience and other market-specific or other relevant assumptions that it believes to be reasonable under the circumstances and adjusts when facts and circumstances dictate. The estimates are the basis for making judgments about the carrying values of assets and liabilities and recorded expenses that are not readily apparent from other sources. As future events and their effects cannot be determined with precision, actual results may materially differ from those estimates or assumptions.</font></div></div>

Files In Submission

Name View Source Status
0001618835-19-000031-index-headers.html Edgar Link pending
0001618835-19-000031-index.html Edgar Link pending
0001618835-19-000031.txt Edgar Link pending
0001618835-19-000031-xbrl.zip Edgar Link pending
evfm-1231201810xk.htm Edgar Link pending
evfm-12312018ex23110k.htm Edgar Link pending
evfm-12312018ex31110k.htm Edgar Link pending
evfm-12312018ex31210k.htm Edgar Link pending
evfm-12312018ex32110k.htm Edgar Link pending
evfm-20181231.xml Edgar Link completed
evfm-20181231.xsd Edgar Link pending
evfm-20181231_cal.xml Edgar Link unprocessable
evfm-20181231_def.xml Edgar Link unprocessable
evfm-20181231_lab.xml Edgar Link unprocessable
evfm-20181231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image2a03.jpg Edgar Link pending
image3a03.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tgdatarequestdec2018v1a02.jpg Edgar Link pending